Vladimir N Ivanov Selected Research

Vladimir N Ivanov Research Topics

Disease

16	Melanoma (Melanoma, Malignant) 07/2015 - 05/2003
12	Neoplasms (Cancer) 01/2019 - 02/2002
6	Glioblastoma (Glioblastoma Multiforme) 09/2021 - 12/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2016 - 07/2015
2	Brain Neoplasms (Brain Tumor) 12/2014 - 03/2014
2	Skin Neoplasms (Skin Cancer) 06/2007 - 01/2006
1	Wounds and Injuries (Trauma) 07/2015
1	Pathologic Processes 07/2015
1	Liver Neoplasms (Liver Cancer) 04/2013
1	Neuroblastoma 12/2011
1	Genomic Instability 06/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2009
1	Acute Promyelocytic Leukemia 12/2006
1	Leukemia 05/2004
1	Neoplasm Metastasis (Metastasis) 05/2003

Drug/Important Bio-Agent (IBA)

9	sodium arsenite (sodium metaarsenite)IBA 07/2015 - 05/2006
7	NF-kappa B (NF-kB)IBA 04/2009 - 05/2003
6	arseniteIBA 03/2008 - 05/2004
5	CannabidiolIBA 09/2021 - 09/2017
5	Phosphotransferases (Kinase)IBA 12/2019 - 06/2003
4	Death Domain ReceptorsIBA 07/2015 - 05/2003
4	Transcription Factors (Transcription Factor)IBA 02/2013 - 05/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 05/2004
4	Fas Ligand Protein (Fas Ligand)IBA 06/2007 - 05/2003
3	ArsenicIBA 09/2016 - 05/2004
3	Proteins (Proteins, Gene)FDA Link 12/2011 - 03/2008
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 04/2009 - 05/2003
3	LigandsIBA 04/2009 - 01/2005
2	Thymidine Monophosphate (TMP)IBA 09/2016 - 07/2015
2	CytokinesIBA 07/2015 - 02/2011
2	Insulin (Novolin)FDA Link 07/2015 - 07/2010
2	Interleukin-8 (Interleukin 8)IBA 12/2014 - 02/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 02/2011
2	Drinking WaterIBA 04/2013 - 02/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2011 - 02/2011
2	TNF-Related Apoptosis-Inducing LigandIBA 07/2010 - 01/2005
2	ResveratrolIBA 06/2008 - 03/2008
2	fas Receptor (CD95 Antigen)IBA 05/2006 - 02/2002
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2005 - 05/2004
1	zinc protoporphyrinIBA 09/2016
1	AntioxidantsIBA 07/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 07/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Serum-Free Culture MediaIBA 07/2015
1	tetramethylpyrazineIBA 07/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015
1	Glutathione (Reduced Glutathione)IBA 07/2015
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 07/2015
1	NestinIBA 07/2015
1	Lovastatin (Mevacor)FDA LinkGeneric 12/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2011
1	Simvastatin (Zocor)FDA LinkGeneric 12/2011
1	Heme Oxygenase-1IBA 12/2011
1	Caspase 8 (Caspase-8)IBA 12/2011
1	DNA (Deoxyribonucleic Acid)IBA 06/2011
1	Monoclonal AntibodiesIBA 02/2011
1	Growth Factor ReceptorsIBA 07/2010
1	Ataxia Telangiectasia Mutated ProteinsIBA 04/2009
1	Small Interfering RNA (siRNA)IBA 04/2009
1	2- morpholin- 4- yl- 6- thianthren- 1- yl- pyran- 4- oneIBA 04/2009
1	Pharmaceutical PreparationsIBA 12/2006
1	Apoptosis Regulatory ProteinsIBA 12/2006
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2006
1	Dynamins (Dynamin)IBA 01/2006
1	Mitogen-Activated Protein KinasesIBA 01/2005
1	Transforming Growth Factor alpha (TGF-alpha)IBA 01/2005
1	ErbB Receptors (EGF Receptor)IBA 01/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2005
1	CarcinogensIBA 05/2004
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2004
1	GTP-Binding Proteins (G-Protein)IBA 05/2003
1	Protein Kinases (Protein Kinase)IBA 05/2003
1	Amino Acids FDA Link 05/2003

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
5	Therapeutics 01/2019 - 05/2003
1	Radiotherapy 01/2020
1	Cranial Irradiation 03/2014